Connect with us

/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Radian Announces First Quarter 2019 Financial Results

Published

on

Reading Time: 13 minutes

— GAAP net income increases to $171 million; diluted net income per
share grows 50% year-over-year to $0.78 —

— Adjusted diluted net operating income per share increases 24%
year-over-year to $0.73 —

— MI in force increases 10% year-over-year to $224 billion —

— Book value per share grows 24% year-over-year to $17.49 —

— Company purchases shares of its common stock under most recent
share repurchase program —

— In April, company enhances risk profile and improves capital
position with closing of $562 million ILN transaction; improves
financial flexibility with additional $375 million return of capital
from Radian Guaranty to Radian Group

PHILADELPHIA–(BUSINESS WIRE)–Radian Group Inc. (NYSE: RDN) today reported net income for the quarter
ended March 31, 2019, of $171.0 million, or $0.78 per diluted share.
This compares to net income for the quarter ended March 31, 2018, of
$114.5 million, or $0.52 per diluted share.

 

Key Financial Highlights (dollars in millions, except
per-share data)

     

Quarter Ended March 31,
2019

   

Quarter Ended March 31,
2018

   

Percent
Change

Net income (1)     $171.0     $114.5     49%
Diluted net income per share     $0.78     $0.52     50%
Consolidated pretax income     $216.1     $142.4     52%
Adjusted pretax operating income (2)     $202.1     $164.1     23%

Adjusted diluted net operating
income per share (2)

    $0.73     $0.59     24%
Net premiums earned – mortgage insurance     $261.8     $242.6     8%
MI New Insurance Written (NIW)     $10,900     $11,664     (7)%
MI primary insurance in force     $223,734     $204,025     10%
Book value per share     $17.49     $14.16     24%
Return on Equity (1)(3)     19.0%     15.1%     26%
Adjusted Net Operating Return on Equity (2)     17.7%     17.1%     4%
           
(1)  

Net income for the first quarter of 2019 includes a $21.9
million pretax net gain on investments and other financial
instruments. Net income for the first quarter of 2018 includes a
$18.9 million pretax net loss on investments and other financial
instruments.

(2)

Adjusted results, including adjusted pretax operating income,
adjusted diluted net operating income per share, and adjusted net
operating return on equity, are non-GAAP financial measures. For
definitions and a reconciliation of these measures to the
comparable GAAP measures, see Exhibits F and G.

(3)

Calculated by dividing annualized net income by average
stockholders’ equity, based on the average of the beginning and
ending balances for each period presented.

 

Adjusted pretax operating income for the quarter ended March 31, 2019,
was $202.1 million, compared to $164.1 million for the quarter ended
March 31, 2018. Adjusted diluted net operating income per share for the
quarter ended March 31, 2019, was $0.73, an increase of 24 percent
compared to $0.59 for the quarter ended March 31, 2018.

Book value per share at March 31, 2019, was $17.49, an increase of 7
percent compared to $16.34 at December 31, 2018, and an increase of 24
percent compared to $14.16 at March 31, 2018. A $78.4 million after-tax
change in accumulated other comprehensive income, due to net unrealized
gains on investment securities, increased book value per share by $0.37
during the first quarter of 2019.

“I am pleased to report on another excellent first quarter for Radian,
with net income of $171 million, return on equity of 19%, and the fifth
consecutive quarter of 10% year-over-year growth in our mortgage
insurance in-force portfolio, which grew to $224 billion. These results
are driven by the fundamental strength of our business model,” said
Radian’s Chief Executive Officer Rick Thornberry. “We continue to
enhance our risk profile and improve our financial flexibility, and are
pleased that our strong financial position has afforded us the
opportunity to return value more quickly to our stockholders through our
share repurchases.”

FIRST QUARTER HIGHLIGHTS

  • Mortgage insurance NIW was $10.9 billion for the quarter, representing
    a decrease of 14 percent compared to $12.7 billion in the fourth
    quarter of 2018 and a decrease of 7 percent compared to $11.7 billion
    in the prior-year quarter.

    • Of the $10.9 billion in NIW in the first quarter of 2019, 83
      percent was written with monthly and other recurring premiums
      compared to 83 percent in the fourth quarter of 2018, and 79
      percent a year ago.
    • Borrower-paid originations accounted for 95 percent of total NIW
      in the first quarter of 2019, compared to 94 percent in the fourth
      quarter of 2018, and 83 percent a year ago.
    • Purchase originations accounted for 92 percent of total NIW in the
      first quarter of 2019, compared to 95 percent in the fourth
      quarter of 2018, and 89 percent a year ago.
  • Total primary mortgage insurance in force as of March 31, 2019, grew
    to $223.7 billion, an increase of 1 percent compared to $221.4 billion
    as of December 31, 2018, and an increase of 10 percent compared to
    $204.0 billion as of March 31, 2018.

    • Radian’s mortgage insurance portfolio consists of 94 percent of
      new business written after 2008, including those loans that
      successfully completed the Home Affordable Refinance Program
      (HARP).
    • Persistency, which is the percentage of mortgage insurance that
      remains in force after a 12-month period, was 83.4 percent as of
      March 31, 2019, compared to 83.1 percent as of December 31, 2018,
      and 81.0 percent as of March 31, 2018.
    • Annualized persistency for the three months ended March 31, 2019,
      was 85.4 percent, compared to 85.5 percent for the three months
      ended December 31, 2018, and 84.3 percent for the three months
      ended March 31, 2018.
  • Net mortgage insurance premiums earned were $261.8 million for the
    quarter ended March 31, 2019, compared to $259.7 million for the
    quarter ended December 31, 2018, and $242.6 million for the quarter
    ended March 31, 2018.

    • Mortgage insurance in force premium yield was 48.6 basis points in
      the first quarter of 2019, compared to 49.0 basis points in the
      fourth quarter of 2018 and 48.7 basis points in the first quarter
      of 2018.
    • Total net mortgage insurance premium yield, which includes the
      impact of ceded premiums and accrued profit commission, was 47.0
      basis points in the first quarter of 2019, compared to 47.4 basis
      points in the fourth quarter of 2018, and 47.9 basis points in the
      first quarter of 2018.
    • Additional details regarding notable variable items impacting
      premiums earned may be found in Exhibit D.
  • The mortgage insurance provision for losses was $20.8 million in the
    first quarter of 2019, compared to $27.1 million in the fourth quarter
    of 2018, and $37.4 million in the prior-year quarter.

    • The number of primary delinquent loans was 20,122 as of March 31,
      2019, a decrease of 5 percent compared to 21,093 as of
      December 31, 2018 and a decrease of 18 percent compared to 24,597
      as of March 31, 2018.
    • The primary mortgage insurance delinquency rate decreased to 2.0
      percent in the first quarter of 2019, compared to 2.1 percent in
      the fourth quarter of 2018, and 2.5 percent in the first quarter
      of 2018.
    • The loss ratio in the first quarter of 2019 was 8.0 percent,
      compared to 10.4 percent in the fourth quarter of 2018, and 15.4
      percent in the first quarter of 2018.
    • Mortgage insurance loss reserves were $385.4 million as of
      March 31, 2019, compared to $397.9 million as of December 31,
      2018, and $485.2 million as of March 31, 2018.
  • Total mortgage insurance claims paid were $34.6 million in the first
    quarter of 2019, compared to $39.7 million in the fourth quarter of
    2018, and $59.9 million in the first quarter of 2018. In addition, the
    company’s pending claim inventory declined 3 percent from March 31,
    2018.
  • Total Mortgage and Real Estate Services Segment revenues for the first
    quarter of 2019 were $36.0 million, compared to $41.5 million for the
    fourth quarter of 2018, and $34.2 million for the first quarter of
    2018. Segment results for the first quarter of 2019 include revenues
    of approximately $5.1 million and incremental expenses (comprised of
    approximately $3.6 million of operating expenses and approximately
    $2.2 million of cost of services), both related to businesses acquired
    in 2018. Adjusted earnings before interest, income taxes, depreciation
    and amortization (Services adjusted EBITDA) for the quarter ended
    March 31, 2019 was a loss of $0.9 million, compared to income of $3.2
    million for the quarter ended December 31, 2018, and income of $0.5
    million for the quarter ended March 31, 2018. Additional details
    regarding the non-GAAP measure Services adjusted EBITDA may be found
    in Exhibits F and G.
  • Other operating expenses were $78.8 million in the first quarter of
    2019, compared to $77.3 million in the fourth quarter of 2018, and
    $63.2 million in the first quarter of 2018. The change in expenses
    year-over-year is primarily driven by $5.7 million of non-operating
    items, $3.6 million related to businesses acquired in 2018 as
    previously mentioned, and an increase in legal and other professional
    services of $1.6 million.

CAPITAL AND LIQUIDITY UPDATE

The company remains focused on optimizing its capital position,
enhancing its return on capital, and increasing its financial
flexibility.

Radian Group

  • As of March 31, 2019, Radian Group maintained $718 million of
    available liquidity. Total liquidity, which includes the company’s
    $268 million unsecured revolving credit facility entered into in
    October 2017, was $986 million as of March 31, 2019.
  • In March 2019, the company announced the Board’s authorization to
    increase its existing share repurchase program from $100 million to
    $250 million and extend the term to July 31, 2020. This program
    provides Radian the flexibility to repurchase shares opportunistically
    from time to time and to spend up to $250 million, excluding
    commissions, based on market and business conditions, stock price and
    other factors. During the first quarter, Radian repurchased and
    settled 1,546,674 shares of its common stock. In addition, as of April
    26, 2019, the company repurchased an additional 4,131,329 shares. As
    of April 26, 2019, total shares repurchased in 2019 were 5,678,003,
    representing a total approximate value of $122.4 million or $21.56 per
    share inclusive of commissions. At April 26, 2019, purchase authority
    of up to approximately $128 million remained available under this
    program, which expires on July 31, 2020.
  • After consideration of the shares repurchased after quarter end and
    the $375 million return of capital described below, Radian Group’s
    available liquidity would have increased by approximately $284 million
    relative to the amount as of March 31, 2019.

Radian Guaranty

  • At March 31, 2019, Radian Guaranty’s Available Assets under the
    Private Mortgage Insurer Eligibility Requirements (PMIERs) totaled
    approximately $3.5 billion, resulting in an excess or “cushion” of
    approximately $488 million, or 16 percent over its Minimum Required
    Assets of approximately $3.0 billion.
  • In April 2019, Radian Guaranty announced the closing of its second
    mortgage insurance-linked note (ILN) transaction, where the company
    obtained $562 million of credit risk protection from Eagle Re 2019-1
    Ltd. (Eagle Re) through the issuance by Eagle Re of ILNs to eligible
    third-party capital markets investors in an unregistered private
    offering. Eagle Re is a special purpose insurer domiciled in Bermuda
    and is not a subsidiary or affiliate of Radian Guaranty. Eagle Re has
    funded its reinsurance obligations by issuing four classes of ILNs
    which have a 10-year maturity with a 7-year call option. The ILNs are
    non-recourse to Radian Group or its subsidiaries and affiliates.
  • The Pennsylvania Insurance Department approved a $375 million return
    of capital from Radian Guaranty to Radian Group during the second
    quarter of 2019, which was paid on April 30, 2019 from Radian
    Guaranty’s gross paid in and contributed statutory surplus. As
    previously reported, the Pennsylvania Insurance Department approved a
    $450 million return of capital in the fourth quarter of 2018. These
    strategic capital actions improve Radian Group’s financial flexibility.
  • After consideration of the ILN transaction and the $375 million return
    of capital described above, Radian Guaranty’s excess of Available
    Assets over its Minimum Required Assets under PMIERs would have
    increased by approximately $187 million.

CONFERENCE CALL

Radian will discuss first quarter financial results in a conference call
tomorrow, Wednesday, May 1, 2019, at 9:00 a.m. Eastern time. The
conference call will be broadcast live over the Internet at http://www.radian.biz/page?name=Webcasts
or at www.radian.biz.
The call may also be accessed by dialing 800.230.1074 inside the U.S.,
or 612.288.0340 for international callers, using passcode 466411 or by
referencing Radian.

A replay of the webcast will be available on the Radian website
approximately two hours after the live broadcast ends for a period of
one year. A replay of the conference call will be available
approximately two and a half hours after the call ends for a period of
two weeks, using the following dial-in numbers and passcode:
800.475.6701 inside the U.S., or 320.365.3844 for international callers,
passcode 466411.

In addition to the information provided in the company’s earnings news
release, other statistical and financial information, which is expected
to be referred to during the conference call, will be available on
Radian’s website under Investors>Quarterly Results, or by clicking on http://www.radian.biz/page?name=QuarterlyResults.

2019 INVESTOR DAY

Radian will host an Investor Day on Tuesday, May 7, 2019, from 9:30 a.m.
to 3:30 p.m. Eastern time in Philadelphia. The company’s senior leaders
will provide details on Radian’s business strategy and priorities, key
business and product initiatives, and financial objectives. The event
will be broadcast live over the Internet at http://www.radian.biz/page?name=Webcasts.
The slide presentation will also be available on Radian’s website one
hour prior to the event and can be accessed by visiting http://www.radian.biz/page?name=Presentations.
A replay of the webcast will be available at http://www.radian.biz/page?name=Webcasts
following the live broadcast, for a period of one year.

NON-GAAP FINANCIAL MEASURES

Radian believes that adjusted pretax operating income, adjusted diluted
net operating income per share and adjusted net operating return on
equity (non-GAAP measures) facilitate evaluation of the company’s
fundamental financial performance and provide relevant and meaningful
information to investors about the ongoing operating results of the
company. On a consolidated basis, these measures are not recognized in
accordance with accounting principles generally accepted in the United
States of America (GAAP) and should not be considered in isolation or
viewed as substitutes for GAAP measures of performance. The measures
described below have been established in order to increase transparency
for the purpose of evaluating the company’s operating trends and
enabling more meaningful comparisons with Radian’s competitors.

Adjusted pretax operating income is defined as earnings excluding the
impact of certain items that are not viewed as part of the operating
performance of the company’s primary activities, or not expected to
result in an economic impact equal to the amount reflected in pretax
income. Adjusted pretax operating income adjusts GAAP pretax income to
remove the effects of: (i) net gains (losses) on investments and other
financial instruments; (ii) loss on induced conversion and debt
extinguishment; (iii) acquisition-related expenses; (iv) amortization or
impairment of goodwill and other acquired intangible assets; and (v) net
impairment losses recognized in earnings and infrequent or unusual
non-operating items. Adjusted diluted net operating income per share
represents a diluted net income per share calculation using as its basis
adjusted pretax operating income, net of taxes at the company’s
statutory tax rate for the period. Adjusted net operating return on
equity is calculated by dividing annualized adjusted pretax operating
income, net of taxes computed using the company’s statutory tax rate, by
average stockholders’ equity, based on the average of the beginning and
ending balances for each period presented.

In addition to the above non-GAAP measures for the consolidated company,
the company also presents as supplemental information a non-GAAP measure
for the Services segment, representing earnings before interest, income
tax provision (benefit), depreciation and amortization (EBITDA).
Services adjusted EBITDA is calculated by using the Services segment’s
adjusted pretax operating income as described above, further adjusted to
remove the impact of depreciation and corporate allocations for interest
and operating expenses. In addition, the company also has presented a
related non-GAAP measure, Services adjusted EBITDA margin, which is
calculated by dividing Services adjusted EBITDA by GAAP total revenue
for the Services segment. Services adjusted EBITDA and Services adjusted
EBITDA margin are presented to facilitate comparisons with other
services companies, since they are widely accepted measures of
performance in the services industry and are used internally as
supplemental measures to evaluate the performance of our Services
segment.

See Exhibit F or Radian’s website for a description of these items, as
well as Exhibit G for reconciliations to the most comparable
consolidated GAAP measures.

ABOUT RADIAN

Radian is ensuring the American dream of homeownership responsibly and
sustainably through products and services that include industry-leading
mortgage insurance and a comprehensive suite of mortgage, risk, real
estate, and title services. We are powered by technology, informed by
data and driven to deliver new and better ways to transact and manage
risk. Learn more about Radian’s financial strength and flexibility at www.radian.biz
and visit www.radian.com
to see how Radian is shaping the future of mortgage and real estate
services.

 

FINANCIAL RESULTS AND SUPPLEMENTAL INFORMATION CONTENTS
(Unaudited)

For historical trend information, refer to Radian’s quarterly
financial statistics at http://www.radian.biz/page?name=FinancialReportsCorporate.

 
Exhibit A:   Condensed Consolidated Statements of Operations Trend Schedule
Exhibit B: Net Income Per Share Trend Schedule
Exhibit C: Condensed Consolidated Balance Sheets
Exhibit D: Net Premiums Earned – Insurance
Exhibit E: Segment Information
Exhibit F: Definition of Consolidated Non-GAAP Financial Measures
Exhibit G: Consolidated Non-GAAP Financial Measure Reconciliations
Exhibit H: Mortgage Insurance Supplemental Information
New Insurance
Written
Exhibit I: Mortgage Insurance Supplemental Information
Primary Insurance
in Force and Risk in Force
Exhibit J: Mortgage Insurance Supplemental Information
Claims and Reserves
Exhibit K: Mortgage Insurance Supplemental Information
Default Statistics
Exhibit L: Mortgage Insurance Supplemental Information
Reinsurance Programs
 
 
Radian Group Inc. and Subsidiaries
Condensed Consolidated Statements of Operations Trend Schedule
Exhibit A
 
    2019     2018

(In thousands, except per-share amounts)

Qtr 1 Qtr 4     Qtr 3     Qtr 2     Qtr 1
 
Revenues:
Net premiums earned – insurance $ 263,512 $ 261,682 $ 258,431 $ 251,344 $ 242,550
Services revenue 32,753 38,414 36,566 36,828 33,164
Net investment income 43,847 42,051 38,995 37,473 33,956
Net gains (losses) on investments and other financial instruments 21,913 (11,705 ) (4,480 ) (7,404 ) (18,887 )
Other income   1,604     1,031     1,174     1,016     807  
Total revenues   363,629     331,473     330,686     319,257     291,590  
 
Expenses:
Provision for losses 20,754 27,140 20,881 19,337 37,283
Policy acquisition costs 5,893 6,485 5,667 5,996 7,117
Cost of services 24,157 24,939 25,854 24,205 23,126
Other operating expenses 78,805 77,266 70,125 70,184 63,243
Restructuring and other exit costs 113 4,464 925 551
Interest expense 15,697 15,584 15,535 15,291 15,080
Amortization and impairment of other acquired intangible assets   2,187     3,461     3,472     2,748     2,748  
Total expenses   147,493     154,988     145,998     138,686     149,148  
 
Pretax income 216,136 176,485 184,688 180,571 142,442
Income tax provision (benefit)   45,179     36,706     41,891     (28,378 )   27,956  
Net income $ 170,957   $ 139,779   $ 142,797   $ 208,949   $ 114,486  
 
Diluted net income per share $ 0.78 $ 0.64 $ 0.66 $ 0.96 $ 0.52
 
 
Radian Group Inc. and Subsidiaries
Net Income Per Share Trend Schedule
Exhibit B
 

The calculation of basic and diluted net income per share was
as follows:

 
    2019     2018

(In thousands, except per-share amounts)

Qtr 1 Qtr 4     Qtr 3     Qtr 2     Qtr 1
Net income —basic and diluted $ 170,957 $ 139,779 $ 142,797 $ 208,949 $ 114,486
 
Average common shares outstanding—basic 213,537 213,435 213,309 213,976 215,967
Dilutive effect of stock-based compensation arrangements (1)   4,806   4,448   4,593   3,854   3,916
Adjusted average common shares outstanding—diluted   218,343   217,883   217,902   217,830   219,883
 
Basic net income per share $ 0.80 $ 0.65 $ 0.67 $ 0.98 $ 0.53
 
Diluted net income per share $ 0.78 $ 0.64 $ 0.66 $ 0.96 $ 0.52
 

(1)

 

The following number of shares of our common stock equivalents
issued under our share-based compensation arrangements were not
included in the calculation of diluted net income per share
because they were anti-dilutive:

 
          2019     2018

(In thousands)

Qtr 1 Qtr 4     Qtr 3     Qtr 2     Qtr 1
Shares of common stock equivalents 169 337 338 484 170
 
 
Radian Group Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
Exhibit C
 

(In thousands, except per-share amounts)

   

March 31,
2019

  December 31,
2018
    September 30,
2018
    June 30,
2018
    March 31,
2018
 
Assets:
Investments $ 5,475,770 $ 5,153,029 $ 5,028,235 $ 4,873,919 $ 4,668,217
Cash 118,668 95,393 104,413 95,573 122,481
Restricted cash 9,086 11,609 9,925 9,152 7,623
Accounts and notes receivable 89,237 78,652 108,003 94,848 80,068
Deferred income taxes, net 67,697 131,643 134,201 171,293 253,381
Goodwill and other acquired intangible assets, net 56,811 58,998 55,707 59,179 61,465
Prepaid reinsurance premium 408,622 417,628 413,728 405,447 390,241
Other assets   373,678     367,700     415,272     430,077     426,773  
Total assets $ 6,599,569   $ 6,314,652   $ 6,269,484   $ 6,139,488   $ 6,010,249  
 
Liabilities and stockholders’ equity:
Unearned premiums $ 720,159 $ 739,357 $ 747,921 $ 741,296 $ 723,100
Reserve for losses and loss adjustment expense 388,784 401,361 412,460 451,542 488,656
Senior notes 1,031,197 1,030,348 1,029,511 1,028,687 1,027,875
Reinsurance funds withheld 329,868 321,212 352,952 331,776 305,409
Other liabilities   419,470     333,659     379,362     385,051     412,793  
Total liabilities   2,889,478     2,825,937     2,922,206     2,938,352     2,957,833  
 
Common stock 230 231 231 231 233
Treasury stock (895,321 ) (894,870 ) (894,635 ) (894,610 ) (894,191 )
Additional paid-in capital 2,697,724 2,724,733 2,720,626 2,715,426 2,748,233
Retained earnings 1,889,964 1,719,541 1,580,296 1,438,032 1,229,616
Accumulated other comprehensive income (loss)   17,494     (60,920 )   (59,240 )   (57,943 )   (31,475 )
Total stockholders’ equity   3,710,091     3,488,715     3,347,278     3,201,136     3,052,416  
Total liabilities and stockholders’ equity $ 6,599,569   $ 6,314,652   $ 6,269,484   $ 6,139,488   $ 6,010,249  
 
Shares outstanding 212,136 213,473 213,333 213,232 215,543
 
Book value per share $ 17.49 $ 16.34 $ 15.69 $ 15.01 $ 14.16
 
Tangible book value per share (See Exhibit G) $ 17.22 $ 16.06 $ 15.43 $ 14.73 $ 13.88
 
Statutory Capital Ratios
Risk to capital ratio-Radian Guaranty only 13.4 :1 (1) 13.9 :1 12.4 :1 12.5 :1 12.6 :1
Risk to capital ratio-Mortgage Insurance combined 12.4 :1 (1) 12.8 :1 11.7 :1 11.8 :1 11.9 :1
 

(1) Preliminary.

 

Contacts

Emily Riley – Phone: 215.231.1035
Email: [email protected]

Read full story here


Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Cannabis

Medical Cannabis Market Report 2024-2030: Asia-Pacific Set to Witness Robust Growth, Driven by R&D Discovery Initiatives

Published

on

Continue Reading

Cannabis

Rubicon Organics Reports Q1 2024 Financial Results

Published

on

Continue Reading

SCHWAZZE

Schwazze Announces First Quarter 2024 Financial Results

Published

on

schwazze-announces-first-quarter-2024-financial-results

Schwazze Management to Host Conference Call Today at 5:00 p.m. Eastern Time

DENVER, May 15, 2024 /PRNewswire/ — Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe CA: SHWZ) (“Schwazze” or the “Company”), today announced financial and operational results for the first quarter ended March 31, 2024.

“We delivered another period of revenue growth in Q1 as we further refined our retail strategy while contending with the prolonged competitive challenges in Colorado and New Mexico,” said Forrest Hoffmaster, Interim CEO of Schwazze. “Throughout the quarter, we continued to sharpen our pricing and promotional efforts while enhancing the in-store experience, widening assortment, improving in-stock position, and advancing our loyalty program to attract and retain new customers. We also strengthened our wholesale business with quarter-over-quarter growth, while surpassing 30% total door penetration across both states.”

“The Colorado market remains highly competitive with more than 680 active recreational licenses, underscoring the importance of delivering an exceptional customer experience and fully integrated retail support program. Although retail pricing has recently stabilized, Colorado sales in Q1 were down 10% year-over-year due to lower volumes. Nonetheless, we significantly outpaced the market as our sales were up 9%, demonstrating the effectiveness of our operating playbook to compete in challenging environments. We expect to continue driving improvements in customer acquisition, retention, and loyalty as we further increase market share in the state.”

“In New Mexico, the proliferation of new licenses continued to outpace state cannabis sales as store count in Q1 increased 31% year-over-year while the market grew only 13%. In addition to pricing and promotional efforts, we’ve focused on driving traffic into our stores by expanding assortment with high quality flower and delivering an elevated customer experience. The New Mexico regulatory body has also increased its license enforcement efforts in recent months, contributing to more than 70 store closures and a 33% sequential decrease in net new store openings in the first quarter. We will continue to support the New Mexico Cannabis Control Division as it develops its regulatory framework.”

“Over the past four years we have rapidly scaled our footprint through 13 acquisitions, building a leading retail presence in both Colorado and New Mexico. We are beginning to see positive momentum from our pricing and promotional strategy and will remain focused on driving operating efficiencies while further optimizing our assets as we consolidate cultivation facilities and eliminate underperforming stores that do not meet our high-margin thresholds. We believe these initiatives, coupled with our operating playbook and strict cost controls, will enable us to return to stronger levels of profitability moving forward.”

First Quarter 2024 Financial Summary

$ in Thousands USD

Q1 2024

Q4 2023

Q1 2023

Total Revenue

$41,601

$43,325

$40,001

Gross Profit

$17,934

$7,034[1]

$21,849

Operating Expenses

$20,643

$23,276

$16,199

Income (Loss) from Operations

$(2,709)

$(16,242)

$5,650

Adjusted EBITDA[2]

$7,341

$10,953

$14,525

Operating Cash Flow

$(3,700)

$3,452

$(880)

Recent Highlights

  • Announced the grand opening of a medical and recreational dispensary in March under the Everest Apothecary banner in Las Cruces, New Mexico, increasing the Company’s retail footprint to 34 stores across the state.
  • Increased wholesale penetration in the first quarter to more than 30% of total doors in Colorado and New Mexico.
  • Lowell Herb Co. pre-roll sales increased more than 3x quarter-over-quarter in Colorado, where it continues to be the #1 pre-roll in the state.
  • Wana gummy sales up more than 2x quarter-over-quarter in New Mexico.

First Quarter 2024 Financial Results

Total revenue in the first quarter of 2024 increased 4% to $41.6 million compared to $40.0 million for the same quarter last year. The increase was primarily due to growth from new stores compared to the prior year period, partially offset by continued pricing pressure and the proliferation of new licenses in New Mexico.

Gross profit for the first quarter of 2024 was $17.9 million or 43.1% of total revenue, compared to $21.8 million or 54.6% of total revenue for the same quarter last year. The decrease in gross margin was primarily driven by the aforementioned pricing pressure in New Mexico, as well as higher medical sales mix in Colorado.

____________________________

1 Q4 2023 Gross Profit includes one-time, non-cash inventory adjustments of approximately $13.1 million comprised of $3.1 million of product consolidation, obsolescence, and shrinkage expenses, $4.3 million of net realizable value adjustments, and $5.8 million of fair value adjustments on acquired inventory in New Mexico in 2023. 
2  Adjusted EBITDA is a non-GAAP measure as defined by the SEC, and represents earnings before interest, taxes, depreciation, and amortization, adjusted for other income, non-cash share-based compensation, one-time transaction related expenses, or other non-operating costs. The Company uses Adjusted EBITDA as it believes it better explains the results of its core business. See “ADJUSTED EBITDA RECONCILIATION (NON-GAAP)” section herein for an explanation and reconciliations of non-GAAP measure used throughout this release.

Operating expenses for the first quarter of 2024 were $20.6 million compared to $16.2 million for the same quarter last year. The year-ago period benefitted from a payroll tax credit of $3.9M. The remaining increase was primarily driven by personnel expenses and four-wall SG&A costs associated with 21 additional stores in Colorado and New Mexico that are still ramping.

Loss from operations for the first quarter of 2024 was $2.7 million compared to income from operations of $5.6 million in the same quarter last year. Net loss was $16.1 million for the first quarter of 2024 compared to net income of $1.7 million for the same quarter last year.

Adjusted EBITDA for the first quarter of 2024 was $7.3 million compared to $14.5 million for the same quarter last year. The decrease in Adjusted EBITDA was primarily driven by lower gross margin and higher operating expenses associated with the 21 additional stores that are still ramping.

As of March 31, 2024, cash and cash equivalents were $13.2 million compared to $19.2 million on December 31, 2023. Total debt as of March 31, 2024, was $159.7 million compared to $156.8 million on December 31, 2023.

Conference Call

The Company will conduct a conference call today, May 15, 2024, at 5:00 p.m. Eastern time to discuss its results for the first quarter ended March 31, 2024.

Schwazze management will host the conference call, followed by a question-and-answer period. Interested parties may submit questions to the Company prior to the call by emailing [email protected].

Date: Wednesday, May 15, 2024
Time: 5:00 p.m. Eastern time
Toll-free dial-in: (888) 664-6383
International dial-in: (416) 764-8650
Conference ID: 84167910
Webcast: SHWZ Q1 2024 Earnings Call

The conference call will also be broadcast live and available for replay on the investor relations section of the Company’s website at https://ir.schwazze.com.

Toll-free replay number: (888) 390-0541
International replay number: (416) 764-8677
Replay ID: 167910

If you have any difficulty registering or connecting with the conference call, please contact Elevate IR at (720) 330-2829.

About Schwazze

Schwazze (OTCQX: SHWZ) (Cboe CA: SHWZ) is building a premier vertically integrated regional cannabis company with assets in Colorado and New Mexico and will continue to explore taking its operating system to other states where it can develop a differentiated regional leadership position. Schwazze is the parent company of a portfolio of leading cannabis businesses and brands spanning seed to sale.

Schwazze is anchored by a high-performance culture that combines customer-centric thinking and data science to test, measure, and drive decisions and outcomes. The Company’s leadership team has deep expertise in retailing, wholesaling, and building consumer brands at Fortune 500 companies as well as in the cannabis sector.

Medicine Man Technologies, Inc. was Schwazze’s former operating trade name. The corporate entity continues to be named Medicine Man Technologies, Inc. Schwazze derives its name from the pruning technique of a cannabis plant to enhance plant structure and promote healthy growth. To learn more about Schwazze, visit https://schwazze.com/.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include financial outlooks; any projections of net sales, earnings, or other financial items; any statements of the strategies, plans and objectives of our management team for future operations; expectations in connection with the Company’s previously announced business plans; any statements regarding future economic conditions or performance; and statements regarding the intent, belief or current expectations of our management team. Such statements may be preceded by the words “may,” “will,” “could,” “would,” “should,” “expect,” “intends,” “plans,” “strategy,” “prospects,” “anticipate,” “believe,” “approximately,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing,” or the negative of these terms or other words of similar meaning in connection with a discussion of future events or future operating or financial performance, although the absence of these words does not necessarily mean that a statement is not forward-looking. We have based our forward-looking statements on management’s current expectations and assumptions about future events and trends affecting our business and industry. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy. Therefore, forward-looking statements are not guarantees of future events or performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control and cannot be predicted or quantified. Consequently, actual events and results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) regulatory limitations on our products and services and the uncertainty in the application of federal, state, and local laws to our business, and any changes in such laws; (ii) our ability to manufacture our products and product candidates on a commercial scale on our own or in collaboration with third parties; (iii) our ability to identify, consummate, and integrate anticipated acquisitions; (iv) general industry and economic conditions; (v) our ability to access adequate capital upon terms and conditions that are acceptable to us; (vi) our ability to pay interest and principal on outstanding debt when due; (vii) volatility in credit and market conditions; (viii) the loss of one or more key executives or other key employees; and (ix) other risks and uncertainties related to the cannabis market and our business strategy. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC’s website at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise except as required by law.

Investor Relations Contact
Sean Mansouri, CFA or Aaron D’Souza
Elevate IR
(720) 330-2829
[email protected]

MEDICINE MAN TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
For the Periods Ended March 31, 2024 and December 31, 2023
Expressed in U.S. Dollars

 March 31,

December 31, 

2024

2023

 

ASSETS

 

Current Assets

Cash & Cash Equivalents

$

13,151,317

$

19,248,932

Accounts Receivable, net of Allowance for Doubtful Accounts

3,356,032

4,261,159

Inventory

26,382,184

25,787,793

Marketable Securities, net of Unrealized Loss of $347,516 and Loss of $1,816, respectively

108,583

456,099

Prepaid Expenses & Other Current Assets

3,502,310

3,914,064

Total Current Assets

46,500,426

53,668,047

Non-Current Assets

Fixed Assets, net Accumulated Depreciation of $10,061,700 and $8,741,782, respectively

31,326,000

31,113,630

Investments

2,000,000

2,000,000

Investments Held for Sale

202,111

Goodwill

67,492,705

67,499,199

Intangible Assets, net Accumulated Amortization of $36,483,160 and $32,706,765, respectively

162,391,482

166,167,877

Other Non-Current Assets

1,328,187

1,263,837

Operating Lease Right of Use Assets

34,575,832

34,233,142

Deferred Tax Assets, net

992,144

1,996,489

Total Non-Current Assets

300,106,350

304,476,285

Total Assets

$

346,606,776

$

358,144,332

 

LIABILITIES & STOCKHOLDERS’ EQUITY

 

Current Liabilities

Accounts Payable

$

9,443,233

$

13,341,561

Accrued Expenses

8,106,618

7,774,691

Derivative Liabilities

1,319,845

638,020

Lease Liabilities – Current

5,186,316

4,922,724

Current Portion of Long Term Debt

29,579,713

3,547,011

Income Taxes Payable

28,235,039

25,232,782

Total Current Liabilities

81,870,764

55,456,789

Non-Current Liabilities

Long Term Debt, net of Debt Discount & Issuance Costs

130,120,753

153,262,203

Lease Liabilities – Non-Current

30,735,072

30,133,452

Total Non-Current Liabilities

160,855,825

183,395,655

Total Liabilities

$

242,726,589

$

238,852,444

Stockholders’ Equity

Preferred Stock, $0.001 Par Value. 10,000,000 Shares Authorized; 82,185 Shares Issued and

82,185 Outstanding as of March 31, 2024 and 85,534 Shares Issued and 85,534 Outstanding as of

December 31, 2023.

82

86

Common Stock, $0.001 Par Value. 250,000,000 Shares Authorized; 79,168,539 Shares Issued

and 78,248,389 Shares Outstanding as of March 31, 2024 and 74,888,392 Shares Issued

and 73,968,242 Shares Outstanding as of December 31, 2023.

79,169

74,888

Additional Paid-In Capital

202,677,665

202,040,968

Accumulated Deficit

(96,843,602)

(80,790,927)

Common Stock Held in Treasury, at Cost, 920,150 Shares Held as of March 31, 2024 and

920,150 Shares Held as of December 31, 2023.

(2,033,127)

(2,033,127)

Total Stockholders’ Equity

103,880,187

119,291,888

Total Liabilities & Stockholders’ Equity

$

346,606,776

$

358,144,332

MEDICINE MAN TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME AND (LOSS)
For the Periods Ended March 31, 2024 and 2023
Expressed in U.S. Dollars

For the Three Months Ended

March 31,

2024

2023

(Unaudited)

(Unaudited)

Operating Revenues

Retail

$

37,633,252

$

35,820,111

Wholesale

3,898,320

4,058,925

Other

69,421

121,900

Total Revenue

41,600,993

40,000,936

Total Cost of Goods & Services

23,667,319

18,152,163

Gross Profit

17,933,674

21,848,773

Operating Expenses

Selling, General and Administrative Expenses

11,835,818

10,100,934

Professional Services

1,671,881

1,187,364

Salaries

6,880,988

4,695,971

Stock Based Compensation

253,916

214,544

Total Operating Expenses

20,642,603

16,198,813

Income from Operations

(2,708,929)

5,649,960

Other Income (Expense)

Interest Expense, net

(8,307,369)

(7,745,854)

Unrealized Gain (Loss) on Derivative Liabilities

(681,825)

8,501,685

Other Loss

10,500

Loss on Investment

(33,382)

Unrealized Gain on Investment

(347,516)

1,816

Total Other Income (Expense)

(9,359,592)

757,647

Pre-Tax Net Income (Loss)

(12,068,521)

6,407,607

Provision for Income Taxes

3,984,154

4,662,178

Net Income (Loss)

$

(16,052,675)

$

1,745,429

Less: Accumulated Preferred Stock Dividends for the Period

(2,155,259)

(2,029,394)

Net Income (Loss) Attributable to Common Stockholders

$

(18,207,934)

$

(283,965)

Earnings (Loss) per Share Attributable to Common Stockholders

Basic Earnings (Loss) per Share

$

(0.24)

$

(0.01)

Diluted Earnings (Loss) per Share

$

(0.24)

$

(0.06)

Weighted Average Number of Shares Outstanding – Basic

76,006,932

55,835,501

Weighted Average Number of Shares Outstanding – Diluted

76,006,932

101,608,278

Comprehensive Income (Loss)

$

(16,052,675)

$

1,745,429

MEDICINE MAN TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
For the Periods Ended March 31, 2024 and 2023
Expressed in U.S. Dollars

For the Three Months Ended

March 31,

2024

2023

(Unaudited)

(Unaudited)

Cash Flows from Operating Activities:

Net Income (Loss) for the Period

$

(16,052,675)

$

1,745,429

Adjustments to Reconcile Net Income (Loss) to Cash for Operating Activities

Depreciation & Amortization

5,096,314

6,151,395

Non-Cash Interest Expense

1,031,431

991,184

Non-Cash Lease Expense

2,871,226

2,251,459

Deferred Taxes

1,004,345

(637,225)

Loss on Investment

202,111

Change in Derivative Liabilities

681,825

(8,501,685)

Amortization of Debt Issuance Costs

421,512

421,513

Amortization of Debt Discount

2,303,246

1,999,933

(Gain) Loss on Investments, net

347,516

(1,816)

Stock Based Compensation

640,974

214,544

Changes in Operating Assets & Liabilities (net of Acquired Amounts):

Accounts Receivable

905,127

(118,181)

Inventory

(587,900)

(3,023,251)

Prepaid Expenses & Other Current Assets

411,754

(3,036,801)

Other Assets

(64,350)

360,674

Change in Operating Lease Liabilities

(2,348,703)

(1,531,765)

Accounts Payable & Other Liabilities

(3,566,401)

(3,464,671)

Income Taxes Payable

3,002,257

5,299,403

Net Cash Provided by (Used in) Operating Activities

(3,700,390)

(879,861)

Cash Flows from Investing Activities:

Collection of Notes Receivable

10,631

Purchase of Fixed Assets

(1,532,287)

(2,913,394)

Net Cash Provided by (Used in) Investing Activities

(1,532,287)

(2,902,763)

Cash Flows from Financing Activities:

Payment on Notes Payable

(864,938)

Net Cash Provided by (Used in) Financing Activities

(864,938)

Net (Decrease) in Cash & Cash Equivalents

(6,097,615)

(3,782,624)

Cash & Cash Equivalents at Beginning of Period

19,248,932

38,949,253

Cash & Cash Equivalents at End of Period

$

13,151,317

$

35,166,628

Supplemental Disclosure of Cash Flow Information:

Cash Paid for Interest

$

4,515,205

$

6,540,748

MEDICINE MAN TECHNOLOGIES, INC.
ADJUSTED EBITDA RECONCILIATION (NON-GAAP)
For the Periods Ended March 31, 2024 and 2023
Expressed in U.S. Dollars

For the Three Months Ended

March 31,

2024

2023

Net Income (Loss)

$

(16,052,675)

$

1,745,429

Interest Expense, net

8,307,369

7,745,854

Provision for Income Taxes

3,984,154

4,662,178

Other (Income) Expense, net of Interest Expense

1,052,223

(8,503,501)

Depreciation & Amortization

5,618,834

6,612,814

Earnings Before Interest, Taxes, Depreciation and

Amortization (EBITDA) (non-GAAP)

$

2,909,905

$

12,262,774

Non-Cash Stock Compensation

253,916

214,544

Deal Related Expenses

637,761

1,195,802

Capital Raise Related Expenses

20,760

35,068

Severance

484,561

118,436

Retention Program Expenses

807,500

280,632

Pre-Operating & Dark Carry Expenses

1,053,837

391,917

One-Time Legal Settlements

417,653

Other Non-Recurring Items

754,751

25,707

Adjusted EBITDA (non-GAAP)

$

7,340,644

$

14,524,880

Revenue

41,600,993

40,000,936

Adjusted EBITDA Percent

17.6 %

36.3 %

View original content:https://www.prnewswire.co.uk/news-releases/schwazze-announces-first-quarter-2024-financial-results-302146858.html

Continue Reading
Advertisement

Latest news

Trending on Grassnews

GrassNews.net: Your premier portal for the latest developments in the cannabis industry. We provide timely news, insightful analysis, and in-depth features on everything from legislation changes and business trends, to scientific research and lifestyle topics. Stay informed and navigate the rapidly evolving cannabis landscape with GrassNews.net..

Contact us: [email protected]

Editorial / PR Submissions

Copyright © 2007 - 2024 Hipther Agency. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania